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Abstract
Objective: To study peripartum use of contraception in women taking long-acting reversible contraceptives 
(LARCs).
Material and methods: Observational, cross-sectional, multicenter, nationwide study of women of reproductive 
age (18-49 years) attending a gynecology clinic to request LARCs for the first time or to restart treatment.
Results: The study population comprised 1,660 patients (1,657 evaluable), with a mean (SD) age of 38.6 (5.7) 
years. Most already had children (1.9 [0.7] children/patient). During the previous 5 years, 44% of the patients 
had been pregnant; this was unintended in 10.3% of cases. The main contraceptive method used during the first 
year after the last delivery was the condom (42.7%), followed by oral contraceptives (16.2%), levonorgestrel-re-
leasing intrauterine devices (7.5%), and the vaginal ring (6.5%). We found that 14.4% of women did not use any 
contraceptive method during the first year after delivery.
Conclusions: LARCs, which are highly effective and easy to apply, continue to be underused after delivery in Spain.
Resumen 
Objetivo: estudio de los hábitos anticonceptivos alrededor del embarazo en mujeres que utilizan métodos anti-
conceptivos reversibles de larga duración.
Material y métodos: estudio observacional, transversal, multicéntrico y nacional, en mujeres en edad repro-
ductiva (18-49 años) que acudían a la consulta ginecológica solicitando anticoncepción de larga duración por 
primera vez o para reiniciar tratamiento. 
Resultados: se incluyeron 1.660 mujeres (1.657 válidas), con una edad de 38,6 ± 5,7 años, la mayoría de las cuales 
ya tenía hijos (1,9 ± 0,7 hijos/mujer). Un 44% de las pacientes tuvieron un embarazo en los últimos 5 años de los 
que el 10,3% no fue planificado. El principal método anticonceptivo utilizado durante el primer año después del 
último parto fue el preservativo (42,7%), seguido de los anticonceptivos orales (16,2%), el dispositivo intrauterino 
liberador de levonorgestrel (7,5%) y el anillo vaginal (6,5%). Un 14,4% de las mujeres no utilizaron ningún método 
anticonceptivo durante el primer año posparto. 
Conclusiones: el uso de métodos anticonceptivos reversibles de larga duración, métodos de mayor efectividad 
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INTRODUCTION
Unintended pregnancy continues to be a major public 
health problem throughout the world (1-4). It also cons-
titutes a considerable socioeconomic burden both for 
families and for society as a whole (4). More than half of 
all unintended pregnancies are in women who have used 
at least 1 type of contraceptive method (1,5,6). Therefore, 
every attempt should be made to help women and their 
partners choose the contraceptive method that best suits 
their preferences and needs (1).
Various studies have shown the patterns for use of 
contraceptives that increase the risk of unintended preg-
nancy (7,8), and the importance of long-acting reversible 
contraceptives (LARCs) in reducing the frequency of unin-
tended pregnancy, termination, and recurrent miscarriage 
was recently demonstrated (8-11).
Therefore, the effectiveness of methods requiring grea-
ter intervention by the user (condom, pill, vaginal ring, and 
transdermal patch) is dramatically reduced (12). Misuse 
and problems with these methods are the main causes of 
unintended pregnancy, and, consequently, terminations in 
Spain (HAYA Study: Estudio sobre Hábitos Anticonceptivos 
y Aborto 2009 [Study on Contraceptive Use and Abortion, 
2009], available at www.equipodaphne.es).
LARCs require occasional intervention by a health 
professional, with the user’s involvement limited to a 
medical visit for insertion, administration, replacement, 
or withdrawal. Contraception is therefore considerably 
more effective, since user participation is minimal, and 
the method is less likely to fail owing to poor adherence. 
Thus, these methods stand out as the most effective forms 
of currently available reversible contraception (12-14).
The 4 types of LARCs marketed in Spain are the copper 
intrauterine device (Cu-IUD), the levonorgestrel-releasing 
intrauterine device (LNG-IUD or hormonal IUD), the sub-
dermal etonogestrel implant, and the 3-monthly injection 
of depot medroxyprogesterone acetate.
Despite their greater effectiveness and ease of use, 
LARCs continue to be less common than other methods, 
such as the condom or combined hormonal methods (VII 
Encuesta de Anticoncepción en España 2011 [VII Survey 
on Contraception in Spain 2011], available at www. equi-
podaphne.es). In Spain, the frequency of LARC use is 5.6%, 
which is much lower than that of the condom (35.6%) and 
the pill (16.3%) (15,16). 
Many authors suggest that after delivery, women 
are more receptive to and interested in contraceptive 
methods and have more access to information and gyne-
cologic advice, thus facilitating their decision (17-22).
The postpartum period, when the woman has just given 
birth and is still hospitalized, provides a key opportunity 
to provide advice on contraception and change her habits 
towards a method that is safe and effective and associated 
with greater adherence (17,18,21).
In Spain, no data have been published to date on use of 
contraception, especially LARCs, before and after delivery.
Therefore, in order to evaluate the reasons why Spani-
sh couples choose LARCs, we designed the present obser-
vational, cross-sectional study of women of reproductive 
age who visit their gynecologist requesting information 
on this method. Our objectives were to investigate the 
characteristics of women who had been pregnant during 
the previous 5 years and who had requested information 
on a LARC method. We also examined their use of con-
traception before pregnancy and after delivery. 
In an initial subanalysis of women who chose LNG-
IUD during the visit, we observed that the factors most 
influencing the users’ choice—based mainly on informa-
tion provided by their gynecologist—were effectiveness 
of the method (94%), long duration (62.5%), ease of use 
(61.3%), and safety (59.9%). They also valued additional 
benefits such as reduced bleeding (87.9%), amenorrhea 
(31.8%), and reduced menstrual pain (25.6%). We eva-
luated the use of contraception before and after preg-
nancy.
MATERIAL AND METHODS
Between February and June 2014, we performed an 
epidemiological, observational, cross-sectional study of 
women of reproductive age (18-49 years) who visited 
their gynecologist requesting long-acting contraception 
for the first time or to restart long-acting treatment under 
conditions of daily clinical practice in private gynecology 
clinics throughout Spain. The protocol, informed consent 
document, and all other information for patients were 
reviewed and approved by the Clinical Research Ethics 
Committee/Independent Ethics Committee of Hospital 
Universitario Puerta del Hierro, Madrid, Spain. The study 
was performed according to the principles of the Declara-
tion of Helsinki and its subsequent revisions.
To be included, the participants had to be able to read, 
write, and understand the study, as well as give their writ-
ten informed consent. We excluded women with contrain-
dications for LARCs and women who had been prescribed 
a LARC for noncontraceptive medical use. We also exclu-
ded those women who, in the opinion of the investigator, 
were considered unsuitable for participation in the study 
and those who were participating in a clinical trial.
The objective of the present subanalysis of the study 
results was to investigate the characteristics of women 
who had been pregnant during the previous 5 years and 
who had attended the clinic to request LARCs. We also 
examined their use of contraceptives before and after 
delivery.
Sociodemographic data were collected at a single visit 
using the clinical history and a custom electronic case 
report form. The data included demographic data, mater-
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nity, characteristics of pregnancy (intended/unintended), 
previous contraception (including methods used before 
pregnancy and after delivery, duration of use), and LARC 
prescribed (IUD, implant, injectable). All data were entered 
into an on-line database.
The statistical analysis was performed using SAS® Ver-
sion 9.3 for Windows
RESULTS
Sociodemographic characteristics
A total of 1,660 women were recruited. Of these 
1,657 (99.8%) were considered suitable for analysis. Of 
the 3 women excluded (0.2%), 2 (0.1%) were not pres-
cribed a LARC during the study visit and 1 (0.1%) had diffi-
culty reading, writing, and understanding the study.
Mean age was 38.6 (5.7) years, and most women 
were Spanish (93.5%), although a few were from Sou-
th America (3.4%) or other European countries (2.2%). 
Most were living with a stable partner (89.6%) and 
were educated to secondary level (36.1%) or university 
level (51.9%) (10.2% were educated only as far as pri-
mary level) (Table I). During the study, 83.1% of women 
were working (employees, 64.4%; self-employed, 18.7%). 
Very few women were unemployed (8.6% had worked 
previously, and 0.2% were looking for their first job) or 
homemakers (7.1%).
Most of those surveyed (83.0%) reported having seen 
a health professional for advice on contraception or for a 
yearly gynecologic check-up. Very few women saw a heal-
th care professional less frequently (11.5% every 2 years; 
2% every 3 years; 3.1% only when necessary).
A very high percentage of users had already had children 
(91.6%, with a mean of 1.9 [0.7] children per woman). As 
for the wish to become pregnant in the future, 78.7% did 
not wish to have more children, 13.7% had not yet deci-
ded, and only 7.6% wanted to wait a mean of 3.8 (1.8) 
years before having more children (median, 3 years) 
(Table I). The mean age of women who wished to have 
more children in the future was 31.2 (5.3) years.
Use of contraceptives
We found that 95.5% of women had experience with 
contraceptives, mainly the male condom (77.7%) and oral 
contraceptives (65.6%), followed by LNG-IUD (23.1%), 
Cu-IUD (18%), and the vaginal ring (17%).
Furthermore, 4.5% of women had never used con-
traceptives, the main reason being the desire to beco-
me pregnant (40.5%). However, 44.6% did not use any 
method, thus entailing a risk of unintended pregnancy. 
Pregnancies during the previous 5 years
A pregnancy during the previous 5 years was recorded 
for 44% of the patients interviewed; of these, 88.9% were 
planned. Among the unintended pregnancies (10.3%), 
6.6% were not wanted. In the remaining 3.7%, the women 
did not plan to have more children, yet they did not use 
contraception, since they did not mind becoming preg-
nant again (Fig. 1A).
In the case of women who had an unintended preg-
nancy, the main reason was failure of the contraceptive 
Table I.
Sociodemographic characteristics (n=1657)
Mean (SD) age, y 38.6 (5.7) 
Previous pregnancy   
    Yes (%) 91.6% 
    No (%) 8.4%
Mean (SD) no. of children 1.9 (0.7)
Wish to become pregnant   
    Yes (%) 7.6% 
    No (%) 78.7%
    Don’t know (%) 13.7%
Origin   
    Europe   
         Spain (%) 93.5% 
         Other European country (%) 2.2% 
    America   
         South America (%) 3.4% 
         North America (%) 0.1% 
    Asia (%) 0.7% 
    Africa (%) 0.2% 
Living with partner   
    Yes (%) 89.6%
    No (%) 10.4% 
Previous use of LARC   
    Yes  (%) 36.7%
    No  (%) 63.3% 
LARC requested   
    LNG-IUD (%) 97.3%
    Cu-IUD (%) 2.7%
    Implant (%) 0.1% 
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method (58.3%). The main methods used by these women 
at the time of the failure were the condom (44.4%) and 
oral contraceptives (18.5%). Other reasons for an unin-
tended pregnancy were failure to use a contraceptive 
method (25%), considering breastfeeding to be a risk-free 
period (10.4%), and the belief on the part of the woman 
that she was infertile (6.3%) (Fig. 1B and 1C).
Contraceptive methods used before pregnancy
The main contraceptive methods used by women 
who had been pregnant during the previous 5 years 
(n = 729) were the condom (33.1%) and oral contra-
ceptives (29.2%); other methods were used much less 
frequently (vaginal ring [7.8%], Cu-IUD [3.7%], LNG-IUD 
[2.6%], and patch [1.5%]). In these cases, the percentage 
of women who did not use any method reached 12.9%.
We observed a difference in the use of the various types 
of IUD depending on the number of children in women 
who planned their pregnancy: those that had only given 
birth once preferred the Cu-IUD, whereas those who had 
had more children preferred the LNG-IUD (Figure 2).
Contraceptive methods used after delivery
The main contraceptive methods used during the first 
year after the last delivery were the condom (42.5%) and 
oral contraceptives (15.9%), followed by LNG-IUD (6.3%), 
vaginal ring (5.5%), and Cu-IUD (4%) (Figure 3A). We 
observed differences in the use of the various methods 
depending on the desire to become pregnant, with a low 
percentage of LARC methods recorded.
Of note, a high percentage of women (15%) did not use 
any method during this year (Figure 3A), the main rea-
sons being the desire to become pregnant (45%), belief 
that they were not at risk of becoming pregnant (13.8%), 
fear of adverse effects (11%), and absence of sexual rela-
tions (10.1%). Other causes (11.9%) included rest period, 
laziness, and belief that they could not become pregnant 
immediately after delivery or when breastfeeding.
The condom was the most frequently used method 
immediately after delivery, especially during the first 2 
months; other methods were less frequent during this 
period. The Cu-IUD was used mainly from the fourth mon-
th after delivery onward, whereas the LNG-IUD was used 
more frequently from the second and third months after 
delivery (Figure 3B).
LNG-IUD was the method used longest after delivery 
(mean, 7.6 [3.6] months) and had the highest continua-
tion rate (67.4%), followed by the condom, oral contra-
ceptives, and coitus interruptus. Other methods with high 
continuation rates included the Cu-IUD (65.5%) and oral 
contraceptives (52.6%) (Figure 3C, Table II).
n = 729 
Pregnancy during the previous 5 years.
n = 48 
Unintended pregnancy during the last 5 years.
n = 28 
Unintended pregnancy owing to failure 
of the contraceptive method used.
Don't know/No (n = 6)
0.8%
No (n = 48)
6,6%
No, but it didn't
matter (n = 27)
3.7%
Yes (n = 648)
88.8%
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Figure 1A. Types of pregnancy during the last 5 years..
Figure 1B.  Reasons for unintended pregnancy.
Figure 1C. Methods used by women who had an unintended pregnancy.
Figure 1. Analysis of pregnancies and use of contraceptives before 
pregnancy.
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Figure 2. Contraceptive methods used before a planned pregnancy according to the number of children, in patients who chose LNG-IUD.
Figure 3A. Contraceptive methods used by women who had been pregnant during the last 5 years (n = 729). Note 1: Patients could choose more than 
1 option. Note 2: The data shown here refer to the most recent pregnancy.
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DISCUSSION
In Spain, no data have been reported to date on rates 
of pregnancy—both intended and unintended—in 
women who choose a LARC method. The same is true 
of data on the main methods used before and after 
delivery. The present study shows that 44% of women 
who visit their gynecologist to request LARC had been 
pregnant during the previous 5 years. The pregnancy 
was planned in 88.8% of cases and unplanned in 10.3% 
of cases (0.8% did not answer). The rate of unintended 
pregnancy is lower than that recorded in studies from 
other European countries (8,23).
In a study of 1,001 Swedish women, 22% had had 
an unplanned pregnancy. The authors concluded that 
promotion of LARC could be a strategy for reducing the 
rate of unintended pregnancies (8).
Another cross-sectional study performed in more 
than 7,000 pregnant women from various European 
countries (Belgium, Iceland, Denmark, Estonia, Norway, 
and Sweden) found that 19.2% of pregnancies were 
unplanned (23).
Figure 3. Contraceptive methods used during the first year after birth. 
Figure 3B. Time of initiation of the contraceptive method after delivery. 
Figure 3C. Continuity of the various contraceptive methods used during the first year after delivery.  
1 2 3 4 5 6 7 8 9 10 11 12
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Coitus interruptus (n = 10)
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Our findings indicate that the rate of 10.3% could be 
higher if the analysis had been performed in women in 
the general population, since the present study was based 
only on women with higher socioeconomic and cultural 
levels who attended private clinics. Furthermore, it has 
been demonstrated that the reduction in the frequency 
of unplanned pregnancies is associated with high levels 
of economic growth, socioeconomic development, and 
promotion of public health (4). In addition, it has been 
observed that the probability of unplanned pregnancy 
varies with age, stage of life, and relationship with one’s 
partner (23,24). Therefore, it would be necessary to per-
form studies in the general population of Spanish women 
to confirm the rate of unplanned pregnancy in Spain and 
to evaluate associated factors. 
We classified all unintended pregnancies into unwanted 
pregnancies (6.6%) and unplanned pregnancies (3.7%). 
In this sense, a recent study in Germany defined the 
term "mistimed pregnancies", which, in contrast to 
unwanted pregnancies, are characterized by negligent use 
of contraception, a positive reaction to the pregnancy, and 
a more general desire to have the child (24).
We believe that this definition is important if we are to 
focus the problem of unintended pregnancy as unplan-
ned and unwanted, which can be terminated. In order 
to address this high percentage, various experts pro-
pose the use of more effective methods, such as LARC 
(1,8,11), especially after the woman has received infor-
mation and advice from a gynecologist or health profes-
sional (1,18,19,22,25).
The present study focuses mainly on the use of less 
effective methods, such as the condom and oral contra-
ceptives, which have largely been considered to fail, as 
reported elsewhere (7,11,18).
Both before and after delivery, we found a low rate of 
LARC use and considerably high percentages of women who 
did not use any contraceptive method. The main reasons 
for not using any method include factors that expose the 
woman to a new pregnancy such as no perception of risk, 
fear of adverse effects, and other causes (eg, rest period, 
inertia, and belief that they could not become pregnant 
immediately after delivery or when breastfeeding). 
At present, many authors address the postpartum risk 
of pregnancy by supporting immediate postplacental 
insertion of an IUD as a safe and effective method, with 
the specific aim of enhancing contraception within the 
first 6 months after delivery (17-22).
Under these circumstances, when the woman is hos-
pitalized and has just given birth, she is highly motivated 
with respect to contraception, and the gynecologist’s advi-
ce is of paramount importance to ensure that she leans 
towards more effective methods such as LARC (17,18).
In situations where contact with health services is more 
difficult, access to advice and immediate instruction on 
contraception, especially LARC-based methods, may not 
be possible, thus leading to higher percentages of unplan-
ned pregnancy (8,17,26).
In fact, in a previous subanalysis of this study in women 
who had been prescribed LNG-IUD during the visit, we 
showed that medical advice was crucial in the choice of 
LARC method, with most value placed on effectiveness, 
long duration, ease of use, and safety. Value was also 
attributed to benefits with respect to the symptoms of 
menstruation (paper in progress).
Therefore, given the low percentage of LARC use we 
recorded, it is necessary to take measures in the Spanish 
public health system so that woman can have access to 
information and to medical/gynecologic counseling with 
respect to the efficacy and safety of LARC. 
CONCLUSIONS
We can conclude that as LARCs continue to be used 
infrequently in Spain, both before and after delivery, mea-
sures are necessary to increase information and medical/
gynecologic counseling with respect to this type of con-
traception and thus avoid unplanned pregnancies. These 
methods include insertion of an IUD immediately after 
delivery or at the end of the first month of puerperium.
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